GSA CAPITAL PARTNERS LLP - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$402
-74.6%
126,812
-49.6%
0.03%
-82.7%
Q4 2022$1,581
-99.5%
251,384
+689.4%
0.20%
+326.1%
Q3 2022$344,000
-74.6%
31,846
-78.6%
0.05%
-74.7%
Q1 2022$1,356,000
-20.8%
148,804
+29.6%
0.18%
-15.3%
Q4 2021$1,713,000
+370.6%
114,815
+723.0%
0.22%
+424.4%
Q2 2021$364,000
+27.7%
13,951
+23.8%
0.04%
-12.8%
Q4 2020$285,000
+3.3%
11,273
+6.1%
0.05%
+46.9%
Q4 2019$276,00010,6220.03%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders